Tech Company Financing Transactions

Bioscience Vaccines Funding Round

Bioscience Vaccines closed a investment round on 2/18/2010. Investors included BioCrossroads.

Transaction Overview

Announced On
2/18/2010
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Accelerate the development of biologic materials, which may boost the effectiveness of a wide range of life-saving vaccines.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1400 Cumberland Ave. c
West Lafayette, IN 47906
USA
Email Address
Overview
Bioscience Vaccines is engaged in the development of vaccine adjuvants and companion products for infectious diseases.
Profile
Bioscience Vaccines LinkedIn Company Profile
Social Media
Bioscience Vaccines Company Twitter Account
Company News
Bioscience Vaccines News
Facebook
Bioscience Vaccines on Facebook
YouTube
Bioscience Vaccines on YouTube

Management Team

Title
Name
Email & Social
Chief Financial Officer
Anthony Hubbard
  Anthony Hubbard LinkedIn Profile  Anthony Hubbard Twitter Account  Anthony Hubbard News  Anthony Hubbard on Facebook
Chief Scientific Officer
Mark Suckow
  Mark Suckow LinkedIn Profile  Mark Suckow Twitter Account  Mark Suckow News  Mark Suckow on Facebook
VP - Operations
Amy Overby
  Amy Overby LinkedIn Profile  Amy Overby Twitter Account  Amy Overby News  Amy Overby on Facebook
VP - R & D
Rae Ritchie
  Rae Ritchie LinkedIn Profile  Rae Ritchie Twitter Account  Rae Ritchie News  Rae Ritchie on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/17/2010: ecoATM venture capital transaction
Next: 2/18/2010: Moblyng venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary